DEUTSCHE BANK AG\ - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$165,000
+38.7%
8,985
+38.1%
0.00%
Q3 2020$119,000
+33.7%
6,507
+10.1%
0.00%
Q2 2020$89,000
+39.1%
5,908
+46.1%
0.00%
Q1 2020$64,000
-5.9%
4,045
-5.7%
0.00%
Q4 2019$68,000
+36.0%
4,291
+25.5%
0.00%
Q3 2019$50,000
-67.1%
3,420
-63.5%
0.00%
Q2 2019$152,000
-39.2%
9,368
-35.5%
0.00%
Q1 2019$250,000
-6.4%
14,532
-4.2%
0.00%
Q4 2018$267,000
-72.2%
15,168
-71.4%
0.00%
Q3 2018$962,000
+20.7%
53,093
+30.2%
0.00%
Q2 2018$797,00040,790
+131480.6%
0.00%
Q1 2018$0
-100.0%
31
-74.8%
0.00%
Q4 2017$1,0000.0%1230.0%0.00%
Q3 2017$1,0000.0%1230.0%0.00%
Q2 2017$1,000
-97.1%
123
-96.0%
0.00%
Q1 2017$35,000
-63.2%
3,038
-58.7%
0.00%
Q4 2016$95,000
+216.7%
7,354
+251.5%
0.00%
Q3 2016$30,000
+30.4%
2,092
+7.3%
0.00%
Q2 2016$23,000
-11.5%
1,950
+33.8%
0.00%
Q1 2016$26,000
-49.0%
1,457
-40.0%
0.00%
Q4 2015$51,000
+13.3%
2,427
-10.6%
0.00%
Q3 2015$45,000
-48.9%
2,715
+14.8%
0.00%
Q2 2015$88,000
-20.0%
2,364
-32.5%
0.00%
Q1 2015$110,0003,5000.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q2 2019
NameSharesValueWeighting ↓
S. MUOIO & CO. LLC 52,468$964,0001.05%
Olympiad Research LP 54,795$1,007,0000.58%
Alpine Global Management, LLC 119,902$2,204,0000.45%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,922$1,212,0000.19%
First Trust Capital Management L.P. 32,688$601,0000.17%
GLAZER CAPITAL, LLC 232,103$4,266,0000.15%
Walleye Capital LLC 105,000$1,930,0000.13%
Yakira Capital Management, Inc. 17,588$323,0000.08%
Dynamic Technology Lab Private Ltd 17,929$330,0000.05%
EQUITEC PROPRIETARY MARKETS, LLC 10,600$195,0000.05%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders